Panaceo "MED" for IBS (Irritable Bowel Syndrome)
NCT03817645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2021-03-24
Summary
Zeolite clinoptilolite is a volcanic mineral from the group of zeolites. The porous structure is associated with a large inner surface. Due to the anionic framework charge, ions (e.g., Pb\^2+) can be absorbed or exchanged. The specific Panaceo PMA zeolite is approved as a class IIa medical device for the repair of the intestine inner lining. It is CE certified and complies with the relevant European Union regulations in terms of safety and effectiveness. Zeolite is known for its absorbing properties. Because of these properties and the results of several human studies, it warrants the investigation of possible effects on specific indications in human medicine, e.g. irritable bowel syndrome.
The diagnosis "irritable bowel syndrome (IBS)" is according to the ROME Foundation, an US medical society. IBS is a disorder with dysfunction of the bowels, a latent inflammation is discussed. The present study aims to evaluate the following effects in patients with IBS:
* Primary endpoint: effect on the symptoms of IBS.
* Secondary endpoint: intestinal wall permeability, integrity of the tight junctions as measured by the change in zonulin concentration in the stool.
* Further endpoints:
* Inflammation parameters and anti-inflammatory laboratory parameters.
* Biodiversity of the gastrointestinal microbiome.
* histamine-associated parameters.
* Constipation as a possible side effect.
For this purpose, a double-blind randomized controlled trial (RCT) is realized prospectively in a monocentric outpatient-controlled study. The subjects take the test compound daily (verum, reference substance) for 12 weeks and document the intake of the study-substance, intake of medications, stool-frequency and consistency. They receive "before" and "after" the intervention phase a blood and stool analysis for the determination of parameters for intestinal wall integrity (zonulin) inflammation (hsCRP, interleukin-10, calprotectin), histamine metabolism, microbiome diversity. The pilot study is realized ahead of the detailed planning of a later main study.
Conditions
- Irritable Bowel Syndrome
- Microbial Colonization
- Intestinal Disease
Interventions
- OTHER
-
Zeolite
The natural zeolite clinoptilolite is of volcanic origin. The mineral belongs to the group of zeolite minerals. Zeolites are silicates with a microporous structure. This results in a stable structure with nanometer-sized cavities that pass through the natural zeolite clinoptilolite - comparable to a mineral sponge. Due to the numerous pores and channels, the mineral has a large internal surface and it can absorb molecules that are smaller in diameter than the pore openings. Since zeolite clinoptilolite has an anionic charge, there are cations such as Na +, K +, Ca 2+, Mg 2+ which can be exchanged for other ions (e.g., Pb\^2+) in the cavities for electrical charge balance. In particular, the ion exchange capacity is essential for the effect and is used in many areas.
Sponsors & Collaborators
-
Scigenia GmbH
lead OTHER
Principal Investigators
-
Ventzislav Petkov, M.D. · Physician
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-09
- Primary Completion
- 2019-06-30
- Completion
- 2020-06-30
Countries
- Austria
Study Locations
More Related Trials
-
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
NCT05016024 ·Status: COMPLETED ·Phase: NA
-
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT00460811 ·Status: COMPLETED ·Phase: PHASE2
-
Pentabiocel in Pediatric IBS
NCT06720805 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pain Relief In Irritable Bowel Syndrome
NCT02573844 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT01880424 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)
NCT06432569 ·Status: COMPLETED ·Phase: NA
-
Mesotherapy Treatment of Irritable Bowel Syndrome
NCT06261320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
NCT01722318 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid
NCT01449487 ·Status: COMPLETED ·Phase: PHASE1
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
NCT01717404 ·Status: COMPLETED ·Phase: PHASE1
-
Vivatlac in Irritable Bowel Syndrome II (ViIBS2)
NCT07235215 ·Status: RECRUITING ·Phase: NA
-
Mesalazine Therapy in Patients With Irritable Bowel Syndrome
NCT00626288 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
NCT00258193 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Diarrhea Predominant Irritable Bowel Syndrome in Females
NCT00461526 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome
NCT02431533 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
NCT03931785 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients
NCT04340661 ·Status: TERMINATED ·Phase: NA
-
IQP-CL-101 in IBS Management
NCT01774825 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
NCT03270085 ·Status: COMPLETED ·Phase: PHASE2
-
Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
NCT02111603 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years
NCT00793494 ·Status: TERMINATED ·Phase: PHASE2
-
Atrantil for Intestinal Bacterial Overgrowth
NCT04755673 ·Status: COMPLETED ·Phase: NA